PharmaTelevision - BayBio CEO Gail Maderis explains their role in supporting the 1300 life sciences companies in Northern California

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BayBio CEO Gail Maderis explains their role in supporting the 1300 life sciences companies in Northern California

Visitors: You are watching a 30 seconds preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Gail Maderis, CEO of BayBio.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

BayBio: Role and purpose

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at BIO 2011 in Washington. On this show I have Gail Maderis, who is President & CEO of BayBio, welcome to the show.

Gail Maderis:

Thank you, it's a pleasure to be here.

Fintan Walton:

I mentioned that BayBio is in Northern California, of course it represents largely the biotechnology companies in the Bay area itself but a little bit beyond that as well, could you just tell us what is the purpose of BayBio?

Gail Maderis:

BayBio's purpose is to support the 1300 life sciences companies in Northern California, to advocate for them at the state level, federal and municipal and to help innovation thrive and support companies in growing and succeeding.

Fintan Walton:

And obviously when organization like yours your role is as you already indicated is very, very important the important thing of course for them is that you represent their needs particularly in a difficult economic time, so what sort of examples could you give where you've worked in an advocacy role at a state level?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Gail Maderis

President

Gail Maderis is President & CEO of BayBio, the industry organization representing and supporting Northern California's life science community. As a former biotech CEO, Ms. Maderis brings deep experience and commitment to supporting the industry through enterprise development, peer-to-peer experience sharing, advocacy and support of education and workforce development. From 2003 to 2009, Ms. Gail Maderis served as President and CEO of FivePrime Therapeutics , Inc., a privately held protein discovery and development company. At FivePrime, she successfully funded the company's rapid growth through substantial private equity financings and corporate partnerships and took the company's first novel cancer therapeutic from discovery into clinical trials. Prior to FivePrime, Ms. Gail Maderis held senior executive positions at Genzyme Corporation, including founder and president of Genzyme Molecular Oncology (GZMO). Ms. Maderis practiced management and strategy consulting with Bain & Co. She serves on the boards of NovaBay, BayBio, the Mayor's Biotech Advisory Council of San Francisco and the HBS Healthcare Initiative. She received a BS in business from the UC Berkeley and an MBA from Harvard Business School.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

BayBio

The BayBio is an independent, non-profit 501(c)(6) trade association serving the life science industry in Northern California. The staff and services of BayBio are paid primarily through memberships, sponsorships, and event registration fees. BayBio provides these services through representatives in South San Francisco and through coalition partners in Washington, DC. Through advocacy, membership services, programs and more, BayBio brings the world's greatest life science community to your fingertips. With the support of more than 450 member organizations, BayBio is delivering the next generation association to you today.